Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05948826 |
| Title | First in Human Study of TORL-3-600 in Participants With Advanced Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | TORL Biotherapeutics, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Providence Medical Foundation | Fullerton | California | 92835 | United States | Details | |
| UCLA - JCCC Clinical Research Unit | Los Angeles | California | 90095 | United States | Details | |
| Sarah Cannon Research Institute | Denver | Colorado | 80218 | United States | Details | |
| Fort Wayne Medical Oncology and Hematology Inc. | Fort Wayne | Indiana | 46845 | United States | Details | |
| Washington University School of Medicine-Siteman Cancer Center | St Louis | Missouri | 63110 | United States | Details | |
| Sarah Cannon Research Institute-Tennessee | Nashville | Tennessee | 37203 | United States | Details | |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details | |
| University Health Network, Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| McGill University Health Centre | Montreal | Quebec | H4A 3J1 | Canada | Details |